Optimisation of oral anticoagulants for patients with atrial fibrillation within 12 months after percutaneous coronary intervention: A meta-analysis and systematic review

BACKGROUND: The optimal antithrombotic strategy, especially regarding oral anticoagulants (OACs) for atrial fibrillation (AF) patients with bleeding and thrombosis risk after percutaneous coronary intervention (PCI), remains unknown. This study explored the optimal oral anticoagulants for AF patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuo, Liu, Ying, Wang, Linxin, Zuo, Haiqi, Tian, Yanfeng, Wang, Yimeng, Yin, Dechun, Zhang, Haiyu, Tian, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349768/
https://www.ncbi.nlm.nih.gov/pubmed/34401468
http://dx.doi.org/10.1016/j.ijcha.2021.100850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349768/
https://www.ncbi.nlm.nih.gov/pubmed/34401468
http://dx.doi.org/10.1016/j.ijcha.2021.100850

Ejemplares similares